Literature DB >> 28131661

Timing and severity of post-discharge morbidity after hepatectomy.

Mustafa Raoof1, Aaron Lewis1, Leanne Goldstein1, Sinziana Dumitra1, Susanne G Warner1, Gagandeep Singh1, Yuman Fong1, Laleh Melstrom2.   

Abstract

BACKGROUND: In order to decrease cost and increase healthcare quality there is an ongoing effort to reduce readmissions after complex operations. The timing and severity of post-discharge complications after hepatectomy need to be better defined.
METHODS: All patients undergoing liver resection at a single institution from Jan 2009-Jun 2015 were included. Complications were scored using the comprehensive complication index (CCI). Multivariate analysis is performed using logistic regression. Receiver operating characteristics (ROCs) were analyzed to optimize the Readmission Risk Index (RRI).
RESULTS: Of the 258 patients that met the inclusion criteria, 26 (10%) were readmitted within 30 days of discharge after hepatectomy. On multivariate analysis age ≥68 years (OR 3.76; 95% CI 1.47-9.63, p = 0.006), CCI ≥ 15 (OR 3.65; 95% CI 1.39-9.56, p = 0.008), maximum temperature within 48 h of discharge (OR 3.02; 95% CI 1.17-7.75, p = 0.022) and white blood cell count ≥10.2 billion cells/L within 48 h of discharge (OR 2.88; 95% CI 1.04-8, p = 0.043) were independent predictors of 30-day readmission. These variables were used to develop the RRI (ROC area 0.80; 95% CI 0.70-0.9, p < 0.001).
CONCLUSION: The CCI and pre-discharge variables can help identify individuals at risk of readmission. Readmission risk reduction efforts should focus on this subset of patients.
Copyright © 2017 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28131661      PMCID: PMC5509751          DOI: 10.1016/j.hpb.2016.12.012

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  15 in total

1.  Underlying reasons associated with hospital readmission following surgery in the United States.

Authors:  Ryan P Merkow; Mila H Ju; Jeanette W Chung; Bruce L Hall; Mark E Cohen; Mark V Williams; Thomas C Tsai; Clifford Y Ko; Karl Y Bilimoria
Journal:  JAMA       Date:  2015-02-03       Impact factor: 56.272

2.  Definition of Readmission in 3,041 Patients Undergoing Hepatectomy.

Authors:  Kristoffer W Brudvik; Yoshihiro Mise; Claudius Conrad; Giuseppe Zimmitti; Thomas A Aloia; Jean-Nicolas Vauthey
Journal:  J Am Coll Surg       Date:  2015-02-28       Impact factor: 6.113

3.  Risk stratification for readmission after major hepatectomy: development of a readmission risk score.

Authors:  Michael E Egger; Malcolm H Squires; David A Kooby; Shishir K Maithel; Clifford S Cho; Sharon M Weber; Emily R Winslow; Robert C G Martin; Kelly M McMasters; Charles R Scoggins
Journal:  J Am Coll Surg       Date:  2014-12-20       Impact factor: 6.113

4.  Revisiting hospital readmissions.

Authors:  Brent I Fox; Bill G Felkey
Journal:  Hosp Pharm       Date:  2013-12

5.  Hospital readmissions after liver surgery for metastatic colorectal cancer.

Authors:  Dietmar Tamandl; Jean M Butte; Peter J Allen; Michael I D'Angelica; Ronald P DeMatteo; Jeffrey S Groeger; William R Jarnagin; Yuman Fong
Journal:  Surgery       Date:  2015-02       Impact factor: 3.982

6.  Variation in surgical-readmission rates and quality of hospital care.

Authors:  Thomas C Tsai; Karen E Joynt; E John Orav; Atul A Gawande; Ashish K Jha
Journal:  N Engl J Med       Date:  2013-09-19       Impact factor: 91.245

7.  Factors predictive of readmission after hepatic resection for hepatocellular carcinoma.

Authors:  Charles W Kimbrough; Steven C Agle; Charles R Scoggins; Robert C G Martin; Michael R Marvin; Eric G Davis; Kelly M McMasters; Christopher M Jones
Journal:  Surgery       Date:  2014-07-30       Impact factor: 3.982

8.  The comprehensive complication index: a novel continuous scale to measure surgical morbidity.

Authors:  Ksenija Slankamenac; Rolf Graf; Jeffrey Barkun; Milo A Puhan; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2013-07       Impact factor: 12.969

Review 9.  Preventing 30-day hospital readmissions: a systematic review and meta-analysis of randomized trials.

Authors:  Aaron L Leppin; Michael R Gionfriddo; Maya Kessler; Juan Pablo Brito; Frances S Mair; Katie Gallacher; Zhen Wang; Patricia J Erwin; Tanya Sylvester; Kasey Boehmer; Henry H Ting; M Hassan Murad; Nathan D Shippee; Victor M Montori
Journal:  JAMA Intern Med       Date:  2014-07       Impact factor: 21.873

10.  Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.

Authors:  Daniel Dindo; Nicolas Demartines; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

View more
  3 in total

1.  Index versus Non-index Readmission After Hepato-Pancreato-Biliary Surgery: Where Do Patients Go to Be Readmitted?

Authors:  Eliza W Beal; Fabio Bagante; Anghela Paredes; Qinyu Chen; Ozgur Akgul; Katiuscha Merath; Mary E Dillhoff; Jordan M Cloyd; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2018-07-23       Impact factor: 3.452

2.  Evaluating the American College of Surgeons National Surgical Quality Improvement project risk calculator: results from the U.S. Extrahepatic Biliary Malignancy Consortium.

Authors:  Eliza W Beal; Ezra Lyon; Joe Kearney; Lai Wei; Cecilia G Ethun; Sylvester M Black; Mary Dillhoff; Ahmed Salem; Sharon M Weber; Thuy B Tran; George Poultsides; Rivfka Shenoy; Ioannis Hatzaras; Bradley Krasnick; Ryan C Fields; Stefan Buttner; Charles R Scoggins; Robert C G Martin; Chelsea A Isom; Kamron Idrees; Harveshp D Mogal; Perry Shen; Shishir K Maithel; Timothy M Pawlik; Carl R Schmidt
Journal:  HPB (Oxford)       Date:  2017-09-07       Impact factor: 3.647

3.  Specialty-Specific Readmission Risk Models Outperform General Models in Estimating Hepatopancreatobiliary Surgery Readmission Risk.

Authors:  Florence E Turrentine; Timothy L McMurry; Mark E Smolkin; R Scott Jones; Victor M Zaydfudim
Journal:  J Gastrointest Surg       Date:  2021-05-04       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.